Workflow
坤恒顺维: 成都坤恒顺维科技股份有限公司关于部分募投项目终止并将剩余募集资金继续存放在募集资金专户的公告

Core Viewpoint - Chengdu Kunheng Shunwei Technology Co., Ltd. has decided to terminate the investment project "Radio Testing Simulation Open Laboratory" and will continue to store the remaining raised funds of 18.6352 million yuan in a special account for raised funds, based on a comprehensive consideration of the actual implementation of the investment projects [1][2][9]. Summary by Sections 1. Basic Situation of Raised Funds - The company issued 21 million shares at a price of 77,857,477.96 yuan, with a net raised fund of 631,942,522.04 yuan, all of which have been received [2][3]. 2. Investment Project Situation - The total planned investment for the raised funds was 291.5988 million yuan, with the project "Radio Testing Simulation Open Laboratory" originally planned for 24 months [3][5]. 3. Termination of Investment Project - The project "Radio Testing Simulation Open Laboratory" was planned with an investment of 24.5898 million yuan, but due to slow progress and changes in market conditions, the company has decided to terminate it [5][7][8]. 4. Reasons for Termination - The project faced slow construction progress due to changes in business development plans and market environment. The existing regional open laboratories and marketing centers are deemed sufficient for current business needs [7][8]. - The equipment planned for demonstration in the open laboratories has become outdated due to rapid product updates, necessitating a shift to self-funded investments for new demonstration equipment [8] . 5. Future Use of Remaining Funds - The remaining funds will be stored in the special account for raised funds and will be used for future projects that align with the company's main business [9][10]. 6. Impact of the Termination - The decision to terminate the project is seen as beneficial for resource allocation and aligns with the company's long-term development plan, ensuring no adverse impact on normal operations [9][10]. 7. Review Procedures - The decision has been approved by the board and requires shareholder meeting approval, with the sponsor institution providing a favorable review [10].